Regularly monitor patients for common adverse effects. Pay close attention to gastrointestinal symptoms like nausea, diarrhea, and abdominal pain. Severe diarrhea, potentially indicating Clostridium difficile infection, requires immediate medical attention.
Gastrointestinal Monitoring
- Assess bowel movements for frequency, consistency, and presence of blood. Inquire about abdominal pain severity and location. Monitor for signs of dehydration, including decreased urine output and dry mucous membranes.
Central nervous system effects should also be tracked. This includes headache, dizziness, confusion, and insomnia. Report any significant changes in mental status immediately.
Central Nervous System Monitoring
- Use standardized scales to assess cognitive function if indicated. Document any changes in alertness, orientation, or memory. Monitor for seizures, particularly in patients with a history of epilepsy or risk factors.
Cardiovascular effects are less common but serious. Monitor for palpitations, chest pain, or shortness of breath. Obtain electrocardiograms (ECGs) as clinically indicated, especially in high-risk patients.
Cardiovascular Monitoring
Record vital signs (heart rate, blood pressure) at each visit. Obtain an ECG if arrhythmias are suspected. Assess for signs of heart failure, such as edema and shortness of breath.
Finally, closely observe for signs of tendonitis or tendon rupture, particularly in the Achilles tendon. Encourage patients to report any pain or swelling in their tendons.
Musculoskeletal Monitoring
- Instruct patients to immediately report any tendon pain or swelling. Assess range of motion in affected joints. Consider imaging studies (ultrasound, MRI) if tendon injury is suspected.
Remember, prompt reporting of any adverse effects is crucial for effective management.
